Financial Statements for Ligand Pharmaceuticals Inc.

Search Images Maps Play YouTube News Gmail Drive More »

Help | Sign in

Recent Quotes (30 days)

You have no recent quotes

chg | %

Ligand Pharmaceuticals Inc. financials

Watch this stock

Income Statement

Balance Sheet

Cash Flow

View: Quarterly Data | Annual Data

Hide charts

In Millions of USD (except for per share items)	3 months ending 2013-03-31	3 months ending 2012-12-31	3 months ending 2012-09-30	3 months ending 2012-06-30	3 months ending 2012-03-31
Revenue	11.65	13.63	6.38	5.74	5.64
Other Revenue, Total	-	-	-	-	-
Total Revenue	11.65	13.63	6.38	5.74	5.64
Cost of Revenue, Total	0.66	2.33	0.68	0.43	0.15
Gross Profit	10.99	11.31	5.69	5.31	5.48
Selling/General/Admin. Expenses, Total	4.50	4.28	4.38	3.94	3.42
Research & Development	2.46	2.48	2.65	2.85	2.82
Depreciation/Amortization	-	-	-	-	-
Interest Expense(Income) - Net Operating	-	-	-	-	-
Unusual Expense (Income)	1.93	3.00	-2.11	1.66	-0.43
Other Operating Expenses, Total	-	0.00	0.00	-	-
Total Operating Expense	9.56	12.09	5.60	8.89	5.96
Operating Income	2.09	1.55	0.77	-3.15	-0.33
Interest Income(Expense), Net Non-Operating	-	-	-	-	-
Gain (Loss) on Sale of Assets	-	-	-	-	-
Other, Net	0.19	0.24	0.01	0.00	0.25
Income Before Tax	1.37	0.95	-0.05	-3.99	-0.77
Income After Tax	1.30	2.59	-0.19	-4.33	-0.74
Minority Interest	-	-	-	-	-
Equity In Affiliates	-	-	-	-	-
Net Income Before Extra. Items	1.30	2.59	-0.19	-4.33	-0.74
Accounting Change	-	-	-	-	-
Discontinued Operations	-	-	-	-	-
Extraordinary Item	-	-	-	-	-
Net Income	1.50	1.06	-0.19	-2.53	1.13
Preferred Dividends	-	-	-	-	-
Income Available to Common Excl. Extra Items	1.30	2.59	-0.19	-4.33	-0.74
Income Available to Common Incl. Extra Items	1.50	1.06	-0.19	-2.53	1.13
Basic Weighted Average Shares	-	-	-	-	-
Basic EPS Excluding Extraordinary Items	-	-	-	-	-
Basic EPS Including Extraordinary Items	-	-	-	-	-
Dilution Adjustment	0.00	0.00	0.00	0.00	0.00
Diluted Weighted Average Shares	20.28	20.12	19.92	19.75	19.74
Diluted EPS Excluding Extraordinary Items	0.06	0.13	-0.01	-0.22	-0.04
Diluted EPS Including Extraordinary Items	-	-	-	-	-
Dividends per Share - Common Stock Primary Issue	0.00	-	0.00	0.00	0.00
Gross Dividends - Common Stock	-	-	-	-	-
Net Income after Stock Based Comp. Expense	-	-	-	-	-
Basic EPS after Stock Based Comp. Expense	-	-	-	-	-
Diluted EPS after Stock Based Comp. Expense	-	-	-	-	-
Depreciation, Supplemental	-	-	-	-	-
Total Special Items	-	-	-	-	-
Normalized Income Before Taxes	-	-	-	-	-
Effect of Special Items on Income Taxes	-	-	-	-	-
Income Taxes Ex. Impact of Special Items	-	-	-	-	-
Normalized Income After Taxes	-	-	-	-	-
Normalized Income Avail to Common	-	-	-	-	-
Basic Normalized EPS	-	-	-	-	-
Diluted Normalized EPS	0.15	0.23	-0.08	-0.16	-0.05

In Millions of USD (except for per share items)	12 months ending 2012-12-31	12 months ending 2011-12-31	12 months ending 2010-12-31	12 months ending 2009-12-31
Revenue	31.39	30.04	23.54	38.94
Other Revenue, Total	-	-	-	-
Total Revenue	31.39	30.04	23.54	38.94
Cost of Revenue, Total	3.60	4.91	0.00	0.00
Gross Profit	27.79	25.13	23.54	38.94
Selling/General/Admin. Expenses, Total	16.11	14.98	12.83	15.21
Research & Development	10.79	10.29	22.07	39.87
Depreciation/Amortization	-	-	-	-
Interest Expense(Income) - Net Operating	-	-	-	-
Unusual Expense (Income)	1.97	3.27	10.51	15.68
Other Operating Expenses, Total	0.00	-1.70	-1.70	-21.85
Total Operating Expense	32.46	31.75	43.70	48.91
Operating Income	-1.08	-1.71	-20.16	-9.97
Interest Income(Expense), Net Non-Operating	-	-	-	-
Gain (Loss) on Sale of Assets	-	-	-	-
Other, Net	0.52	0.63	4.38	-0.22
Income Before Tax	-3.87	-3.56	-15.40	-9.87
Income After Tax	-2.67	9.71	-12.79	-8.34
Minority Interest	-	-	-	-
Equity In Affiliates	-	-	-	-
Net Income Before Extra. Items	-2.67	9.71	-12.79	-8.34
Accounting Change	-	-	-	-
Discontinued Operations	-	-	-	-
Extraordinary Item	-	-	-	-
Net Income	-0.53	9.71	-10.37	-1.95
Preferred Dividends	-	-	-	-
Income Available to Common Excl. Extra Items	-2.67	9.71	-12.79	-8.34
Income Available to Common Incl. Extra Items	-0.53	9.71	-10.37	-1.95
Basic Weighted Average Shares	-	-	-	-
Basic EPS Excluding Extraordinary Items	-	-	-	-
Basic EPS Including Extraordinary Items	-	-	-	-
Dilution Adjustment	0.00	0.00	0.00	0.00
Diluted Weighted Average Shares	19.85	19.71	19.61	18.86
Diluted EPS Excluding Extraordinary Items	-0.13	0.49	-0.65	-0.44
Diluted EPS Including Extraordinary Items	-	-	-	-
Dividends per Share - Common Stock Primary Issue	-	0.00	0.00	0.00
Gross Dividends - Common Stock	-	-	-	-
Net Income after Stock Based Comp. Expense	-	-	-	-
Basic EPS after Stock Based Comp. Expense	-	-	-	-
Diluted EPS after Stock Based Comp. Expense	-	-	-	-
Depreciation, Supplemental	-	-	-	-
Total Special Items	-	-	-	-
Normalized Income Before Taxes	-	-	-	-
Effect of Special Items on Income Taxes	-	-	-	-
Income Taxes Ex. Impact of Special Items	-	-	-	-
Normalized Income After Taxes	-	-	-	-
Normalized Income Avail to Common	-	-	-	-
Basic Normalized EPS	-	-	-	-
Diluted Normalized EPS	-0.07	0.64	-0.25	0.10

In Millions of USD (except for per share items)	As of 2013-03-31	As of 2012-12-31	As of 2012-09-30	As of 2012-06-30	As of 2012-03-31
Cash & Equivalents	5.04	12.38	7.05	8.88	9.78
Short Term Investments	-	0.00	0.00	1.50	1.52
Cash and Short Term Investments	5.04	12.38	7.05	10.38	11.29
Accounts Receivable - Trade, Net	4.62	4.59	2.16	0.82	1.99
Receivables - Other	-	-	-	-	-
Total Receivables, Net	8.88	8.94	6.71	6.87	9.61
Total Inventory	2.84	1.70	2.55	2.70	1.34
Prepaid Expenses	-	0.80	0.89	0.90	1.06
Other Current Assets, Total	0.99	0.00	0.24	0.24	0.24
Total Current Assets	17.74	23.82	17.43	21.10	23.54
Property/Plant/Equipment, Total - Gross	-	5.67	5.65	5.53	5.23
Accumulated Depreciation, Total	-	-4.88	-4.80	-4.88	-4.86
Goodwill, Net	12.24	12.24	12.24	12.24	12.24
Intangibles, Net	55.32	55.91	56.58	57.16	57.74
Long Term Investments	-	-	-	-	-
Other Long Term Assets, Total	12.31	11.50	10.40	11.69	16.13
Total Assets	98.36	104.26	97.51	102.83	110.03
Accounts Payable	5.52	5.85	6.03	6.75	7.89
Accrued Expenses	4.52	4.96	5.38	4.23	4.14
Notes Payable/Short Term Debt	0.00	0.00	0.00	1.50	1.50
Current Port. of LT Debt/Capital Leases	16.23	17.87	13.26	8.86	4.60
Other Current liabilities, Total	6.75	6.75	5.21	9.49	9.07
Total Current Liabilities	33.02	35.44	29.88	30.82	27.21
Long Term Debt	5.49	13.44	17.88	22.21	26.43
Capital Lease Obligations	5.07	5.96	-	-	-
Total Long Term Debt	10.57	19.41	17.88	22.21	26.43
Total Debt	26.80	37.28	31.14	32.57	32.53
Deferred Income Tax	0.79	0.72	2.66	2.52	2.37
Minority Interest	-	-	-	-	-
Other Liabilities, Total	23.39	22.20	25.85	29.80	35.49
Total Liabilities	67.77	77.78	76.27	85.35	91.50
Redeemable Preferred Stock, Total	-	-	-	-	-
Preferred Stock - Non Redeemable, Net	-	-	-	-	-
Common Stock, Total	0.02	0.02	0.02	0.02	0.02
Additional Paid-In Capital	752.95	751.50	747.32	743.37	741.89
Retained Earnings (Accumulated Deficit)	-681.26	-682.76	-683.82	-683.63	-681.10
Treasury Stock - Common	-42.28	-42.28	-42.28	-42.28	-42.28
Other Equity, Total	1.17	-	-	0.00	0.00
Total Equity	30.60	26.48	21.23	17.48	18.53
Total Liabilities & Shareholders' Equity	98.36	104.26	97.51	102.83	110.03
Shares Outs - Common Stock Primary Issue	-	-	-	-	-
Total Common Shares Outstanding	20.22	20.16	19.96	19.79	19.73

In Millions of USD (except for per share items)	As of 2012-12-31	As of 2011-12-31	As of 2010-12-31	As of 2009-12-31
Cash & Equivalents	12.38	7.04	3.35	16.03
Short Term Investments	0.00	10.00	19.35	37.20
Cash and Short Term Investments	12.38	17.04	22.70	53.23
Accounts Receivable - Trade, Net	4.59	6.11	0.99	0.62
Receivables - Other	-	-	-	-
Total Receivables, Net	8.94	12.43	13.74	10.92
Total Inventory	1.70	1.30	0.00	-
Prepaid Expenses	0.80	1.22	0.58	0.85
Other Current Assets, Total	0.00	0.24	0.00	3.17
Total Current Assets	23.82	32.23	37.02	68.17
Property/Plant/Equipment, Total - Gross	5.67	5.23	9.73	20.84
Accumulated Depreciation, Total	-4.88	-4.77	-9.17	-12.32
Goodwill, Net	12.24	12.24	0.70	0.70
Intangibles, Net	55.91	58.33	12.25	1.81
Long Term Investments	-	-	-	-
Other Long Term Assets, Total	11.50	17.33	25.03	62.60
Total Assets	104.26	120.58	75.56	141.81
Accounts Payable	5.85	11.06	8.60	20.71
Accrued Expenses	4.96	8.26	9.86	10.50
Notes Payable/Short Term Debt	0.00	10.00	0.00	0.00
Current Port. of LT Debt/Capital Leases	17.87	-	-	-
Other Current liabilities, Total	6.75	14.32	15.03	20.96
Total Current Liabilities	35.44	43.64	33.49	52.17
Long Term Debt	13.44	20.29	0.00	-
Capital Lease Obligations	5.96	-	-	-
Total Long Term Debt	19.41	20.29	0.00	0.00
Total Debt	37.28	30.29	0.00	0.00
Deferred Income Tax	0.72	2.23	0.37	28.11
Minority Interest	-	-	-	-
Other Liabilities, Total	22.20	37.90	38.20	49.44
Total Liabilities	77.78	104.05	72.06	129.72
Redeemable Preferred Stock, Total	-	-	-	-
Preferred Stock - Non Redeemable, Net	-	-	-	-
Common Stock, Total	0.02	8.37	8.37	8.47
Additional Paid-In Capital	751.50	732.68	729.27	726.82
Retained Earnings (Accumulated Deficit)	-682.76	-682.23	-691.95	-681.57
Treasury Stock - Common	-42.28	-42.28	-42.23	-42.13
Other Equity, Total	-	0.00	0.03	0.51
Total Equity	26.48	16.53	3.50	12.09
Total Liabilities & Shareholders' Equity	104.26	120.58	75.56	141.81
Shares Outs - Common Stock Primary Issue	-	-	-	-
Total Common Shares Outstanding	20.16	19.56	19.51	19.44

In Millions of USD (except for per share items)	3 months ending 2013-03-31	12 months ending 2012-12-31	9 months ending 2012-09-30	6 months ending 2012-06-30	3 months ending 2012-03-31
Net Income/Starting Line	1.50	-0.53	-1.59	-1.40	1.13
Depreciation/Depletion	0.67	2.73	1.98	1.34	0.68
Amortization	-	-	-	-	-
Deferred Taxes	0.07	-1.20	0.45	0.30	-0.04
Non-Cash Items	2.26	1.93	-1.95	-0.64	-1.82
Changes in Working Capital	-2.41	-2.77	-0.90	-0.70	-0.33
Cash from Operating Activities	2.08	0.16	-2.01	-1.10	-0.37
Capital Expenditures	-0.04	-0.59	-0.63	-0.26	-0.02
Other Investing Cash Flow Items, Total	0.00	1.86	1.97	3.96	3.96
Cash from Investing Activities	-0.03	1.26	1.33	3.70	3.94
Financing Cash Flow Items	-	-	-	-	-
Total Cash Dividends Paid	-	-	-	-	-
Issuance (Retirement) of Stock, Net	0.33	6.42	3.18	0.24	0.16
Issuance (Retirement) of Debt, Net	-9.71	-2.50	-2.50	-1.00	-1.00
Cash from Financing Activities	-9.39	3.92	0.68	-0.76	-0.84
Foreign Exchange Effects	-	-	-	-	-
Net Change in Cash	-7.34	5.34	0.01	1.84	2.74
Cash Interest Paid, Supplemental	-	2.45	1.85	1.30	-
Cash Taxes Paid, Supplemental	-	0.00	0.01	0.01	-

In Millions of USD (except for per share items)	12 months ending 2012-12-31	12 months ending 2011-12-31	12 months ending 2010-12-31	12 months ending 2009-12-31
Net Income/Starting Line	-0.53	9.71	-10.37	-1.95
Depreciation/Depletion	2.73	2.79	2.21	4.63
Amortization	-	-	0.00	-
Deferred Taxes	-1.20	-13.40	0.00	0.00
Non-Cash Items	1.93	5.59	6.44	-17.93
Changes in Working Capital	-2.77	-5.87	-25.34	-18.56
Cash from Operating Activities	0.16	-1.17	-27.07	-33.80
Capital Expenditures	-0.59	-0.08	-0.07	-0.52
Other Investing Cash Flow Items, Total	1.86	-25.05	14.61	25.29
Cash from Investing Activities	1.26	-25.13	14.54	24.77
Financing Cash Flow Items	-	0.00	0.00	0.00
Total Cash Dividends Paid	-	-	-	-
Issuance (Retirement) of Stock, Net	6.42	0.00	-0.07	0.23
Issuance (Retirement) of Debt, Net	-2.50	30.00	-0.09	-3.92
Cash from Financing Activities	3.92	30.00	-0.16	-3.69
Foreign Exchange Effects	-	-	-	-
Net Change in Cash	5.34	3.69	-12.69	-12.72
Cash Interest Paid, Supplemental	2.45	2.46	0.06	0.27
Cash Taxes Paid, Supplemental	0.00	0.04	0.03	0.01